Arvinas (ARVN) CSO has shares sold automatically to cover RSU tax withholding

Rhea-AI Filing Summary

Arvinas, Inc. Chief Scientific Officer Angela M. Cacace reported an automatic sale of 2,576 shares of common stock at $7.595 per share. According to the disclosure, the issuer executed this sale to cover tax withholding obligations tied to the vesting and settlement of previously granted restricted stock units, under a durable sale instruction, and it was not a discretionary trade. Following the transaction, Cacace directly holds 180,390 shares of Arvinas common stock.

Insider Trade Summary 10b5-1

Net Seller: 2,576 shares ($19,565)

Net Sell 1 txn

Insider Cacace Angela M

Role Chief Scientific Officer

Sold 2,576 shs ($20K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,576	$7.595	$20K

Holdings After Transaction: Common Stock — 180,390 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 2,576 shares Sale price per share: $7.595 per share Shares held after transaction: 180,390 shares +1 more

4 metrics

Shares sold 2,576 shares Automatic sale to cover RSU tax withholding

Sale price per share $7.595 per share Price for the 2,576-share tax-related sale

Shares held after transaction 180,390 shares Direct holdings after the June 17, 2026 sale

Transaction date June 17, 2026 Date of automatic tax-withholding sale

Key Terms

restricted stock units (RSUs), tax withholding obligations, durable sale instruction, open-market sale

4 terms

restricted stock units (RSUs) financial

"in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs)"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

tax withholding obligations financial

"made automatically by the Issuer to cover tax withholding obligations in connection with the vesting"

durable sale instruction financial

"granted on June 17, 2024 pursuant to a durable sale instruction"

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cacace Angela M

(Last) (First) (Middle)

C/O ARVINAS, INC.

5 SCIENCE PARK, 395 WINCHESTER AVE.

(Street)

NEW HAVEN CONNECTICUT 06511

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARVINAS, INC. [ ARVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2026		S		2,576(1)	D	$7.595	180,390	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on June 17, 2024 pursuant to a durable sale instruction. The sale does not represent a discretionary trade.

Remarks:

	/s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Arvinas (ARVN) disclose for Angela M. Cacace?

Arvinas disclosed that Chief Scientific Officer Angela M. Cacace had 2,576 shares of common stock sold at $7.595 per share. The issuer executed this sale automatically to cover tax withholding tied to RSU vesting, not as a discretionary trade.

Was the Arvinas (ARVN) insider share sale a discretionary trade?

No, the sale was not discretionary. The issuer sold 2,576 shares automatically to satisfy tax withholding obligations from RSU vesting under a durable sale instruction, meaning Cacace did not choose the timing or amount as a market decision.

How many Arvinas (ARVN) shares does Angela M. Cacace hold after this transaction?

After the tax-related sale, Angela M. Cacace directly holds 180,390 shares of Arvinas common stock. This figure reflects her remaining position as reported in the Form 4 following the 2,576-share sale to cover RSU withholding taxes.

What was the price per share in the Arvinas (ARVN) CSO’s reported sale?

The reported sale price was $7.595 per share for 2,576 Arvinas common shares. This transaction was carried out automatically by the issuer to cover RSU-related tax withholding, rather than as an open-market trade initiated by the executive.

Why did Arvinas (ARVN) sell shares held by its Chief Scientific Officer?

The issuer sold 2,576 shares held by the Chief Scientific Officer to cover tax withholding obligations from the vesting and settlement of RSUs granted on June 17, 2024, under a durable sale instruction, rather than for discretionary portfolio or valuation reasons.